Manufacturing Strategy for Multiwalled Carbon Nanotubes as a Biocompatible and Innovative Material

Figure 1

The viability of BEAS-2B cells treated with different MWCNTs. The cells were exposed to MWCNTs for 24 h. The small graph shows the dose effects of NT15 and NT08 on the cell viability. The large graph shows the cell viability associated with 10 μg/mL treatment of each MWCNT in the MWCNT-150 and MWCNT-80 series. (Mean ± SE, 𝑛=6, ^∗𝑃<0.05, ^∗∗𝑃<0.01.)